Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q2 2024
Institutional positions in Terns Pharmaceuticals, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 126
- +15 vs. Q1 2024
- Shares held
- 65.6M
- +2.38M (+3.8%) vs. Q1 2024
- Total value
- $446.7M
- +$32.1M (+7.7%) vs. Q1 2024
- New holders
- 40
- 45 more added
- Sold out
- 25
- 24 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TERN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $75.4K |
| Q1 2026 | 317 | $6.56B |
| Q4 2025 | 248 | $4.95B |
| Q3 2025 | 141 | $665.7M |
| Q2 2025 | 130 | $310.0M |
| Q1 2025 | 138 | $229.4M |
| Q4 2024 | 157 | $477.2M |
| Q3 2024 | 156 | $663.1M |
| Q2 2024 | 126 | $446.7M |
| Q1 2024 | 112 | $414.8M |
| Q4 2023 | 103 | $412.7M |
| Q3 2023 | 93 | $310.4M |
| Q2 2023 | 103 | $505.0M |
| Q1 2023 | 79 | $630.2M |
| Q4 2022 | 65 | $506.2M |
| Q3 2022 | 45 | $178.1M |
| Q2 2022 | 42 | $36.5M |
| Q1 2022 | 44 | $50.0M |
| Q4 2021 | 37 | $116.7M |
| Q3 2021 | 34 | $174.3M |
| Q2 2021 | 36 | $203.8M |
| Q1 2021 | 42 | $393.7M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Terns Pharmaceuticals, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ameritas Investment Partners, Inc. | 5,640 | $38.4K | 0.00% | +2,101+59.4% | Added |
| Legal & General Group Plc | 5,054 | $34.4K | 0.00% | −22,479−81.6% | Reduced |
| California State Teachers Retirement System | 4,171 | $28.4K | 0.00% | −27,939−87.0% | Reduced |
| Quantbot Technologies LP | 3,759 | $25.6K | 0.00% | +3,759 | New |
| Advisor Group Holdings, Inc. | 2,299 | $15.7K | 0.00% | +2,299 | New |
| Mirae Asset Global Investments Co., Ltd. | 1,931 | $13.7K | 0.00% | +1,931 | New |
| Amalgamated Bank | 1,445 | $10.0K | 0.00% | 00.0% | Unchanged |
| HHM Wealth Advisors, LLC | 1,400 | $9.53K | 0.00% | +1,400 | New |
| Federated Hermes, Inc. | 1,216 | $8.28K | 0.00% | +1,216 | New |
| CIBC Private Wealth Group, LLC | 1,000 | $7.53K | 0.00% | +900+900.0% | Added |
| Stone House Investment Management, LLC | 1,000 | $6.81K | 0.00% | 00.0% | Unchanged |
| Meeder Asset Management Inc | 772 | $5.26K | 0.00% | +772 | New |
| US Bancorp | 600 | $4.09K | 0.00% | −95−13.7% | Reduced |
| GAMMA Investing LLC | 413 | $2.81K | 0.00% | −614−59.8% | Reduced |
| Parallel Advisors, LLC | 337 | $2.29K | 0.00% | +126+59.7% | Added |
| ZRC Wealth Management, LLC | 265 | $1.80K | 0.00% | +40+17.8% | Added |
| Daiwa Securities Group Inc. | 151 | $1.00K | 0.00% | 00.0% | Unchanged |
| Capital Advisors, Ltd. LLC | 183 | $1.00K | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 90 | $764 | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 101 | $688 | 0.00% | +57+129.5% | Added |
| National Bank of Canada | 100 | $679 | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 99 | $674 | 0.00% | 00.0% | Unchanged |
| Lindbrook Capital, LLC | 62 | $422 | 0.00% | +62 | New |
| Rothschild Investment LLC | 40 | $272 | 0.00% | +40 | New |
| Farther Finance Advisors, LLC | 27 | $185 | 0.00% | −1−3.6% | Reduced |
| CWM, LLC | 2 | $0 | 0.00% | +2 | New |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −2,003,263−100.0% | Sold out |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −1,363,675−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −450,000−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −250,551−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −227,821−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −137,100−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −74,755−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −71,361−100.0% | Sold out |
| Swiss National Bank | 0 | $0 | 0.00% | −61,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −54,722−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −50,825−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −24,060−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −21,370−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −21,206−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −17,870−100.0% | Sold out |
| Kennedy Capital Management, Inc. | 0 | $0 | 0.00% | −15,466−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −12,121−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −7,782−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −2,395−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −1,814−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −1,400−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −327−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |